Skip to content
Welcome, thoughtbot's Giant Robots listeners!Start here
Enhanced R&D Intensive Support
AI-generated illustration
LegislationGB

Enhanced R&D Intensive Support

UK R&D tax relief for loss-making, research-intensive small firms.

Enhanced R&D Intensive Support is the separate tax-relief route for eligible loss-making, research-intensive small companies. It applies to accounting periods beginning on or after 1 April 2024.

Last refreshed: 22 October 2026 · Appears in 1 active topic

Timeline for Enhanced R&D Intensive Support

#16 29 Sept
View full timeline →

Background

Enhanced R&D Intensive Support, usually called ERIS, is a UK research tax-relief scheme for eligible loss-making small and medium-sized companies. It combines an additional deduction for qualifying research costs with a payable credit against surrenderable losses. It preserves a distinct route for research-intensive businesses within the wider Reform of company research relief. [HMRC scheme history](https://www.GOV.UK/government/statistics/corporate-tax-research-and-development-tax-credit/research-and-development-tax-credits-statistics-september-2026)

Eligibility depends on a company making a tax trading loss before the extra deduction and meeting the research-intensity condition. Connected-company expenditure enters that assessment. The scheme has the same qualifying-cost rules as merged RDEC but calculates relief differently. An eligible business can choose merged RDEC instead, without claiming both schemes on the same expenditure. [HMRC guidance](https://www.GOV.UK/guidance/research-and-development-rd-tax-relief-the-merged-scheme-and-enhanced-rd-intensive-support)

Common Questions
What does ERIS stand for?
Who is ERIS intended to support?
Can a company claim ERIS and merged RDEC on the same spending?
Source Material

Written with AI from Lowdown's published reporting. Not individually reviewed by an editor. Updated 22 October 2026. Editorial standards.